Molecular Analyses of the Genetic Control of Immune Response in Humans
Molecular Analyses of the Genetic Control of Immune Response in Humans
批准号:
63440028
负责人:
SASAZUKI Takehiko
金额:
$19.39万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1990
中文摘要
点击翻译按钮获取中文摘要
英文摘要
HLA class multigene family consists of DR, DQ and DP genes. It is well accepted that HLA-DR acts as immune response (Ir-) gene, because there is a genetic restriction by HLA-DR in T cell-antigen presenting cell interation to respond to foreign antigens, and because anti HLA-DR monoclonal antibody completely abolish the immune response. In human population, there are low (non) responders to natural antigens such as schistosomal antigen, streptococcal antigen, tetanus toxoid, hepatitis B vaccine, etc. after either natural sensitization or planned immunization. Family analysis revealed that the low (non) responsiveness to those antigens in an HLA-linked dominant genetic trait, and therefore the low (non) response can not be explained by a lock of lr-genes. Furthermore strong immune response can be restored in low (non) responders in vitro by either delection of CD8+ T cells or addition of anti HLA-DQ monoclonal antibody suggesting that HLA-DQ may control the antigen specific low immune re … More sponsiveness through an induction of CD8+ suppressor T cells.HLA-DQ alleles of the low and high responders to streptoccocal antigen were determined by investigating a hybridization between sequence specific oligonucleotide probes and HLA genes amplified by polymerase chain reaction. The strong associations between particular HLA-DQ alleles and low or high responders were observed and heterozygotes of high and low responder haplotypes exhibited low reponsiveness confirming that the HAL-DQ linked gene controlled low responsiveness to streptococcal antigen as a dominant genetic trait. In the peripheral blood lymphocytes from low (non) responders to streptococcal antigen, CD4+ T cells restricted by HLA-DR and DQ, respectively, were observed as well as a small fraction of CD8+ T cells if challenged with the antigen. In high responders, on the other hand, only CD4+ T cells restricted by HLA-DR were detected. CD4+ T cells restriced by HLA-DQ in low responders recognized streptococcal M protein by utilizing T cell receptor Vbeta5.3 gene and propagated the proliferation and activation of CD8+T cells whereas CD4+T cells restricted by DR could not do so. The CD8+ T cells expressed T cell receptor V alpha2 and Vbeta5.2 genes and suppresed the antigen specific proliferative response of CD4+ T cells. Thus we conclude that HLA-DQ alleles controls low (non) responsiveness in humans as immune suppresssion (Is) genes. HLA-DQ alleles of the patients with Insulin dependent diabetes mellitus (IDDM) were determined by DNA typing methods desribed above to show strong association between susceptibility or resistance to IDDM. This HLA-DQ associated susceptibility or resisitance to IDDM may be explained by the genetic control of immune response via HLA-DQ as the Is-gene.In an attempt to establish a model mouse for the analysis of biological function of HLA class II molecules in vivo, both the HLA-DQw6 A and B genes were introduced into fertilized eggs of C57BL/6 (B6) mice and a stable line of HLA-DQw6 transgenic B6 mouse (DQw6-B6) was established. The DQw6-B6 acquired an immune responsiveness to SCW and lost an immune responsiveness to E. Coli antigen. Therefore, we succeeded in the alteration of mouse immune response by introducing human MHC class II genes. Less
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sasazuki, T., Iwanaga, T., Inamitsu, T., Yanagawa, Y., Yasunami, M., Kimura, A., Hirokawa, K., and Nishimura, T.: "Expression and function of human major histocompatibility complex HLA-DQw6 genes in the C57BL/6 mouse." Cold Spring Harbor Symposium on Quan
Sasazuki, T.、Iwanaga, T.、Inamitsu, T.、Yanakawa, Y.、Yasunami, M.、Kimura, A.、Hirokawa, K. 和 Nishimura, T.:“人类主要组织相容性复合物的表达和功能
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishimura, Y., Iwanaga, T., Inamitsu, T., Yanagawa, Y., Yasunami, M., Kimura, A., Hirokawa, K., and Sasaziki, T.: "Expression of human major histocompatibility complex, HLA-DQw6 genes alters the immune response in C57BL/6 mice." Journal of Immunology. 145
Nishimura, Y.、Iwanaga, T.、Inamitsu, T.、Yanakawa, Y.、Yasunami, M.、Kimura, A.、Hirokawa, K. 和 Sasaziki, T.:“人类主要组织相容性复合体 HLA 的表达
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
稲光 毅: "MHCと self peptideー免疫応答におけるself peptideの役割" 実験医学. 8. 77-80 (1990)
Takeshi Inamitsu:“MHC 和自身肽 - 自身肽在免疫反应中的作用”实验医学 8. 77-80 (1990)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
西村 泰治: "トランスジェニックマウスを用いたMHCの解析「生化学実験講座」第12巻分子免疫学" 東京化学同人 東京, (1991)
西村太二:“使用转基因小鼠的MHC分析《生物化学实验教程》第12卷分子免疫学”东京化学同人东京,(1991)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Honda, K., Hirayama, K., Kikuchi, I., Nagato, H., Tamai, H., and Sasazuki, T.: "HLA and silicosis in Japan." New England Journal of Medicine. 319. 1610 (1988)
Honda, K.、Hirayama, K.、Kikuchi, I.、Nagato, H.、Tamai, H. 和 Sasazuki, T.:“日本的 HLA 和矽肺。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 51 条
Immunogenetic Analysis of Autoimmune Thyroid Diseases
-
批准号:17019069
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$91.97万
-
财政年份:2005
-
负责人:SASAZUKI Takehiko
-
依托单位:
Mechanisms of oncogenesis and anti-oncogenesis
-
批准号:11178101
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$186.43万
-
财政年份:1999
-
负责人:SASAZUKI Takehiko
-
依托单位:
Development of soluble TCR and soluble MHC/peptide compelx with high affinity for their ligands
-
批准号:08557026
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$7.68万
-
财政年份:1996
-
负责人:SASAZUKI Takehiko
-
依托单位:
Molecular Basis of Immunological Tolerance and Non-Response
-
批准号:08044302
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.76万
-
财政年份:1996
-
负责人:SASAZUKI Takehiko
-
依托单位:
in vitro manipulation of genes relevant to oncogenesis
-
批准号:06454608
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1994
-
负责人:SASAZUKI Takehiko
-
依托单位:
Molecular mechanism of immune regulation and immune tolerance
-
批准号:05272103
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$32.64万
-
财政年份:1993
-
负责人:SASAZUKI Takehiko
-
依托单位:
Molecular mechanisms of immune regulation.
-
批准号:05272104
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$158.14万
-
财政年份:1993
-
负责人:SASAZUKI Takehiko
-
依托单位:
Molecular mechanism of immune response requlated by HLA
-
批准号:05044177
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$8.32万
-
财政年份:1993
-
负责人:SASAZUKI Takehiko
-
依托单位:
Development of HLA bound peptitides which have supressive activity.
-
批准号:04557027
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$12.1万
-
财政年份:1992
-
负责人:SASAZUKI Takehiko
-
依托单位:
Research on the molecular basis for genetic control of immune response in human
-
批准号:03404026
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$17.92万
-
财政年份:1991
-
负责人:SASAZUKI Takehiko
-
依托单位:
The analysis of HLA-linked immune suppression genes and their expression.
-
批准号:60480177
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1985
-
负责人:SASAZUKI Takehiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LILRB2/HLA-G免疫抑制轴在胶质瘤干细胞免疫逃逸中的作用及其与STAT3信号通路的交互调控机制研究
-
批准号:2026JJ80459
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王彪
-
依托单位:
HLA-DR+中性粒细胞调控儿童噬血细胞综合征细胞因子风暴的机制及临床价值研究
-
批准号:2026JJ81611
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘灿
-
依托单位:
HLA-B*13:01介导阿苯达唑肝损伤的毒理机制及构效关系研究
-
批准号:2026JJ50638
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:饶泰
-
依托单位:
肝内胆管细胞癌中TREM2+巨噬细胞通过增强HLA-C/FAM3C信号通路依赖性淋巴管生成促进肿瘤转移的机制研究
-
批准号:QN25H160111
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:万喆
-
依托单位:
HLA-B27通过肠道菌群失衡致炎促AS发展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郑海雅
-
依托单位:
三阴性乳腺癌HLA-I和HLA-II限制性T细胞表位鉴定与免疫治疗
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邵营宽
-
依托单位:
EBV高危亚型编码的BALF2-HR蛋白上调HLA-II类分子促进鼻咽癌免疫逃逸的机制研究
-
批准号:2025JJ60152
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:葛军尚
-
依托单位:
HLA-C 提高CAR-T 细胞治疗急性淋巴细胞白血病效能及机制的探讨
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张诚
-
依托单位:
HLA-G在胃癌发生发展中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:章霞
-
依托单位:
KIR-HLA受配体相合度对免疫性血小板输注无效的影响及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: